Other specified protozoal diseases
ICD-10 B60.8 is a billable code used to indicate a diagnosis of other specified protozoal diseases.
B60.8 encompasses a variety of protozoal infections that do not fall under more specific categories. Protozoal diseases are caused by single-celled organisms and can lead to significant morbidity and mortality, particularly in tropical regions. Common protozoal infections include those caused by Plasmodium species (malaria), Leishmania (leishmaniasis), and Trypanosoma (sleeping sickness). Symptoms can vary widely depending on the specific protozoan involved, ranging from mild gastrointestinal disturbances to severe systemic illness. Diagnosis typically involves laboratory tests such as blood smears, serological tests, or PCR. Treatment protocols vary based on the specific protozoal infection but often include antiparasitic medications such as metronidazole, nitazoxanide, or specific antimalarials. The complexity of diagnosing and treating these infections is compounded by the diverse clinical presentations and the potential for co-infections with other pathogens, particularly in immunocompromised patients.
Detailed clinical notes including symptoms, laboratory results, and treatment plans.
Patients presenting with fever, gastrointestinal symptoms, or travel history to endemic areas.
Ensure thorough documentation of diagnostic tests and treatment response.
Comprehensive patient history, including travel and exposure history, and symptomatology.
Patients with unexplained fever or gastrointestinal symptoms after travel.
Document any referrals to specialists for further evaluation.
Used when confirming a protozoal infection through molecular testing.
Document the specific protozoan tested for and the results.
Infectious disease specialists should ensure accurate coding based on test results.
B60.8 includes various protozoal infections that are not specifically categorized elsewhere, such as certain cases of giardiasis, amoebiasis, and other less common protozoal diseases.
